Home » FzioMed Awarded New U.S. Patent for Oxiplex Biomaterial Technology
FzioMed Awarded New U.S. Patent for Oxiplex Biomaterial Technology
April 12, 2005
FzioMed announced that it has been awarded a new U.S. patent covering the company's Oxiplex technology. Oxiplex is a versatile polymer biomaterial developed by FzioMed for use in a wide variety of surgical specialties. The new patent, U.S. 6,869,938, covers compositions of polyacids and polyethers, and methods for their use in reducing postsurgical adhesions.
Yahoo News (http://biz.yahoo.com/bw/050411/115228.html?.v=1)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct